What is the Share Price of Akums Drugs & Pharmaceuticals Ltd?
- Answer Field
-
The share price of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 572.30 and for BSE is ₹ 570.65.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, AKUMS DRUGS AND PHARMA L share price is currently at ₹ 572.3, which is up by ₹ 2.95 from its previous closing. Today, the stock has fluctuated between ₹ 555.00 and ₹ 578.50. Over the past year, AKUMS DRUGS AND PHARMA L has achieved a return of -28.12 %. In the last month alone, the return has been 11.52 %. Read More...
Particulars | MAR 2025 (Values in Cr) |
---|---|
Revenue | 328.75 |
Operating Expense | 323.75 |
Net Profit | 27.59 |
Net Profit Margin (%) | 8.39 |
Earnings Per Share (EPS) | 1.80 |
EBITDA | 49.78 |
Effective Tax Rate (%) | 25.55 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.36 | 27.76 | 1.99 | 278.64 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 149.35 | 18.67 | 1.49 | 1573.70 | 101.00 / 184.95 |
CIPLA LTD | 1505.40 | 23.06 | 3.89 | 121589.70 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 338.10 | 12.94 | 2.74 | 995.06 | 163.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.36 | 36.36 | 5.74 | 278.64 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 697.60 | 39.68 | 6.17 | 2016.81 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 10524.65 | 150.31 | 34.15 | 26311.63 | 6160.25 / 10653.05 |
BLISS GVS PHARMA LTD | 149.35 | 22.80 | 1.48 | 1573.70 | 101.00 / 184.95 |
Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC.
Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients. Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services. Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation. Their specialization extends to development and sale of APIs across diverse chemical processes and therapeutic areas such as anti-infective, respiratory and diabetes.
In 2004, the Company established first plant for oral dosage commissioned at 19, 20, 21, Sector 6A, Haridwar, Uttarakhand. In 2007, it established dedicated manufacturing site for oral liquid dosage and sterile products both at Haridwar, Uttarakhand. It incorporated Maxcure Nutravedics Limited to venture into nutraceuticals in 2009. In 2010, it dedicated a facility for hormones ; dedicated a facility for cosmetics and dermatology at Haridwar, Uttarakhand. In 2010, it incorporated Akumentis Healthcare Limited to venture into branded formulations.
In 2011, it innovated bi-layered sustained release tablets for the first time. In 2012, acquired subsidiary, Pure and Cure Healthcare Private Limited to expand capacity and capabilities. In 2013, it acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities. It established R&D Laboratory in Mumbai, Maharashtra to venture into regulated market in 2015.
In 2021, the Company acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs. Further, it acquired Kotdwar Plant in Uttarakhand by Akums Healthcare Limited. In 2022, it acquired facility in Haridwar, Uttarakhand through the subsidiaries, Akums Healthcare Limited and in 2023, acquired Baddi facility in, Himachal Pradesh through Pure and Cure Healthcare Private Limited
Following a Scheme of Arrangement on October 17, 2023, Akums Lifesciences Limited got merged with its subsidiary, Pure and Cure Healthcare Private Limited (PCHL) with effect from April 1, 2022. As part of this acquisition, it acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an R&D centre in Barwala, Haryana and commenced operations in the manufacture and sale of key starting materials, intermediates and APIs.
The Company launched an IPO by issuing 27,368,151 equity shares of Rs 2 each by raising funds aggregating to Rs 1857 Crore comprising a fresh issue of 10,037,716 equity shares aggregating to Rs 680 Crore and offer for sale of 17,330,435 equity shares aggregating to Rs 1177 Crore in August, 2024.
The share price of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 572.30 and for BSE is ₹ 570.65.
The market cap of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 8,187.57 Cr. and for BSE is ₹ 8,163.96 Cr. as of now.
The 52 Week High and Low of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 1,175.90 and ₹ 405.00 and for BSE is ₹ 1,174.85 and ₹ 407.40.
You can trade in Akums Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -28.12%.
Akums Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 572.30 & for BSE ₹ 570.65 as on Jun 13 2025 03:30 PM.
The market cap of Akums Drugs & Pharmaceuticals Ltd for NSE ₹ 8,187.57 & for BSE ₹ 8,163.96 as on Jun 13 2025 03:30 PM.
As on Jun 13 2025 03:30 PM the price-to-earnings (PE) ratio for Akums Drugs & Pharmaceuticals Ltd share is 55.84.
As on Jun 13 2025 03:30 PM, the price-to-book (PB) ratio for Akums Drugs & Pharmaceuticals Ltd share is 146.51.
You can trade in Akums Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Akums Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Akums Drugs & Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found